Jane Street
TVRD

Jane Street’s Tvardi Therapeutics TVRD Stock Holding History

Jane Street’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,842
Closed -$1.24M – 11133
2022
Q1 		$1.24M Sell
2,842
-1,180
-29% -$484K ﹤0.01% 5675
2021
Q4 		$1.76M Buy
4,022
+622
+18% +$313K ﹤0.01% 4722
2021
Q3 		$1.89M Buy
3,400
+1,278
+60% +$641K ﹤0.01% 4589
2021
Q2 		$1.09M Sell
2,122
-300
-12% -$190K ﹤0.01% 5645
2021
Q1 		$1.89M Buy
2,422
+103
+4% +$70.5K ﹤0.01% 4128
2020
Q4 		$1.26M Buy
2,319
+1,500
+183% +$786K ﹤0.01% 4281
2020
Q3 		$375K Sell
819
-2,684
-77% -$1.56M ﹤0.01% 5579
2020
Q2 		$2.16M Buy
+3,503
New +$1.93M ﹤0.01% 2957
2018
Q4 		– Sell
-269
Closed -$232K – 5875
2018
Q3 		$232K Sell
269
-812
-75% -$586K ﹤0.01% 4523
2018
Q2 		$745K Buy
1,081
+3
+0.3% +$1.52K ﹤0.01% 3120
2018
Q1 		$480K Buy
+1,078
New +$523K ﹤0.01% 3502
2017
Q3 		– Sell
-1,356
Closed -$751K – 5194
2017
Q2 		$751K Buy
1,356
+920
+211% +$584K ﹤0.01% 2532
2017
Q1 		$289K Sell
436
-558
-56% -$298K ﹤0.01% 3487
2016
Q4 		$333K Buy
994
+36
+4% +$11.6K ﹤0.01% 3260
2016
Q3 		$288K Buy
+958
New +$208K ﹤0.01% 3350

Other funds holding TVRD

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

Jane Street's TVRD Position: Q1 2026 in Review

Jane Street sold out of Tvardi Therapeutics (TVRD) in Q1 2026, closing a stake of 47,444 shares — an estimated $204K sold.

Jane Street first reported a position in TVRD in Q1 2014 and held it in 25 quarters. The position peaked at $3.42M in Q3 2021. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

  • Jane Street reported no remaining Tvardi Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 47,444 Tvardi Therapeutics shares in Q1 2026, an estimated $204K.
  • Jane Street first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 25 quarters.
  • Jane Street's Tvardi Therapeutics position peaked at $3.42M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.